World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
53
Citations
10783
World Ranking
4082
National Ranking
1581

Overview

Jason M. Pogue is affiliated with the University of Michigan-Ann Arbor in the United States. Their research spans primarily the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with notable contributions in subfields such as Molecular Medicine, Applied Microbiology and Biotechnology, Epidemiology, Pharmacology, and Infectious Diseases.

Their work focuses on several main topics, including:

  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Pneumonia and Respiratory Infections
  • Nosocomial Infections in ICU
  • COVID-19 Clinical Research Studies

Jason M. Pogue has authored research papers on a range of clinical and microbiological subjects. Recent publications include:

  • "Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19," 2020, Clinical Infectious Diseases
  • "Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial," 2020, The Lancet Infectious Diseases
  • "Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options," 2020, Open Forum Infectious Diseases
  • "Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms," 2020, Infectious Diseases and Therapy
  • "Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins," 2021, Clinical Microbiology and Infection

Frequent co-authors with whom Jason M. Pogue has collaborated include:

  • Keith S. Kaye
  • Walaiporn Wangchinda
  • Samuel L Aitken
  • Ryan K. Shields
  • Ellen G Kline

Jason M. Pogue's research has been disseminated through several publication venues, with the highest number of publications appearing in:

  • Open Forum Infectious Diseases
  • Clinical Infectious Diseases
  • Antimicrobial Agents and Chemotherapy
  • Infectious Diseases and Therapy
  • Clinical Microbiology and Infection

Best Publications

  • International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

    Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul

  • Tocilizumab for treatment of mechanically ventilated patients with COVID-19.

    Emily C Somers;Gregory A Eschenauer;Jonathan P Troost;Jonathan L Golob

  • Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections

    Haley J. Morrill;Jason M. Pogue;Keith S. Kaye;Kerry L. LaPlante

  • Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

    Richard G. Wunderink;Yuko Matsunaga;Mari Ariyasu;Philippe Clevenbergh

  • Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management

    Keith S. Kaye;Jason M. Pogue

  • Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system

    Jason M. Pogue;Jason M. Pogue;Jiha Lee;Dror Marchaim;Victoria Yee

  • Coronavirus disease 2019 treatment: A review of early and emerging options

    Erin K McCreary;Jason M Pogue

  • Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan

    Dror Marchaim;Teena Chopra;Jason M. Pogue;Federico Perez

  • A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.

    Natalie A. Finch;Evan J. Zasowski;Kyle P. Murray;Ryan P. Mynatt

  • Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.

    Bhagyashri Navalkele;Bhagyashri Navalkele;Jason M. Pogue;Shigehiko Karino;Shigehiko Karino;Bakht Nishan

  • Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa

    Jason M Pogue;Keith S Kaye;Michael P Veve;Twisha S Patel

  • Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations.

    Jason M Pogue;Jason M Pogue;Robert A Bonomo;Robert A Bonomo;Keith S Kaye

  • Agents of Last Resort: Polymyxin Resistance

    Keith S. Kaye;Jason M. Pogue;Thien B. Tran;Roger L. Nation

  • Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens

    J.M. Pogue;K.S. Kaye;D.A. Cohen;D. Marchaim

  • Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.

    Dror Marchaim;Teena Chopra;Ashish Bhargava;Christopher Bogan

  • Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms.

    Janet Y. Wu;Pavithra Srinivas;Jason M. Pogue

  • Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.

    Jason M Pogue;Tal Mann;Katie E Barber;Keith S Kaye

  • Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms.

    Unknown

  • Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin

    Evan J. Zasowski;Kyle P. Murray;Trang D. Trinh;Trang D. Trinh;Natalie A. Finch

  • Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli

    Teena Chopra;Dror Marchaim;Jennifer Veltman;Paul Johnson

  • Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae

    Joshua T. Thaden;Jason M. Pogue;Keith S. Kaye

  • Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.

    Ravina Kullar;Steven N. Leonard;Susan L. Davis;Susan L. Davis;Susan L. Davis;George Delgado

  • Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy

    Anthony M. Casapao;Susan L. Davis;Susan L. Davis;Viktorija O. Barr;Kenneth P. Klinker

Frequent Co-Authors

Keith S. Kaye
Keith S. Kaye Rutgers, The State University of New Jersey
Michael J. Rybak
Michael J. Rybak Wayne State University
Emily T. Martin
Emily T. Martin University of Michigan–Ann Arbor
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Federico Perez
Federico Perez Case Western Reserve University
John S. Bradley
John S. Bradley University of California, San Diego
Sujata M. Bhavnani
Sujata M. Bhavnani University at Buffalo, State University of New York
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Roger L. Nation
Roger L. Nation Monash University
Michael N. Dudley
Michael N. Dudley Qpex Biopharma

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond microbiology, pursuing related online degrees can open up diverse career opportunities. For example, many students consider online public health masters programs easy to get into, which provide a strong foundation in community health, epidemiology, and health policy. These programs are ideal for microbiology graduates aiming to influence public health at a larger scale.

Another career pathway includes becoming a child life specialist, a role focused on supporting children through stressful medical experiences. If you are curious about the financial prospects in this field, resources outlining the child specialist salary can provide valuable insight into the profession’s benefits and challenges.

For those facing unique challenges, such as individuals with criminal records, pursuing higher education might seem daunting. However, there are options tailored to these circumstances. Explore degrees for felons that offer accessible and supportive pathways to career advancement.

Additionally, healthcare professionals with a microbiology background might consider advanced practice roles, such as a functional medicine nurse practitioner. Programs focused on functional medicine np programs integrate holistic and evidence-based approaches, appealing to those interested in innovative patient care models.

Best Scientists Citing Jason M. Pogue

Trending Scientists

Recently Published Articles